V J Bardou
About
V J Bardou is a scholar working on Oncology, Cancer Research and Surgery.
According to data from OpenAlex, V J Bardou has authored 32 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in V J Bardou's work include Breast Cancer Treatment Studies (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (3 papers). V J Bardou is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (3 papers). V J Bardou collaborates with scholars based in France, United States and India. V J Bardou's co-authors include Gary M. Clark, Grazia Arpino, Richard Elledge, Gary C. Chamness, D. Craig Allred, Jiemin Wong, Susan G. Hilsenbeck, Suzanne A.W. Fuqua, Torsten Hopp and C. Kent Osborne and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
In The Last Decade
V J Bardou
32 papers receiving 2.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| V J Bardou France | 18 | 1.2k | 821 | 590 | 553 | 548 | 32 | 2.2k | ||
| H D Sinnett United Kingdom | 20 | 1.1k 0.9× | 986 1.2× | 472 0.8× | 432 0.8× | 371 0.7× | 44 | 2.0k | ||
| Wendy Recant United States | 23 | 972 0.8× | 559 0.7× | 502 0.9× | 764 1.4× | 213 0.4× | 47 | 2.4k | ||
| H. Hausmaninger Austria | 21 | 1.3k 1.2× | 910 1.1× | 287 0.5× | 568 1.0× | 447 0.8× | 53 | 2.2k | ||
| K. Hacène France | 26 | 1.7k 1.5× | 1.2k 1.5× | 462 0.8× | 881 1.6× | 362 0.7× | 76 | 3.2k | ||
| Fujio Kasumi Japan | 30 | 1.4k 1.2× | 1.3k 1.6× | 962 1.6× | 1.4k 2.6× | 790 1.4× | 122 | 3.4k | ||
| Masataka Yoshimoto Japan | 26 | 810 0.7× | 734 0.9× | 518 0.9× | 630 1.1× | 380 0.7× | 84 | 1.8k | ||
| Sami Diab United States | 27 | 1.8k 1.5× | 1.0k 1.2× | 470 0.8× | 812 1.5× | 386 0.7× | 74 | 2.8k | ||
| M. Tubiana-Hulin France | 14 | 987 0.8× | 1.2k 1.4× | 570 1.0× | 279 0.5× | 163 0.3× | 40 | 1.8k | ||
| Volker Möbus Germany | 26 | 1.2k 1.0× | 587 0.7× | 227 0.4× | 493 0.9× | 155 0.3× | 117 | 2.2k | ||
| Stig B. Holmberg Sweden | 20 | 1.4k 1.2× | 1.3k 1.6× | 718 1.2× | 244 0.4× | 275 0.5× | 51 | 2.3k |
Countries citing papers authored by V J Bardou
Since
Specialization
Citations
This map shows the geographic impact of V J Bardou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V J Bardou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V J Bardou more than expected).
Fields of papers citing papers by V J Bardou
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by V J Bardou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V J Bardou. The network helps show where V J Bardou may publish in the future.
Co-authorship network of co-authors of V J Bardou
This figure shows the co-authorship network connecting the top 25 collaborators of V J Bardou. A scholar is included among the top collaborators of V J Bardou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V J Bardou. V J Bardou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Vv, Ivanov, Catherine Faucher, Mohamad Mohty, et al.. (2005). Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplantation. 36(10). 901–906.
2.
Gonçalvès, Anthony, François Bertucci, R Sauvan, et al.. (2005). Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene. 25(7). 981–989.
3.
Bladou, Franck, V J Bardou, Gwénaëlle Gravis, et al.. (2004). Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology. 64(3). 488–493.
4.
Vv, Ivanov, Catherine Faucher, Mohamad Mohty, et al.. (2004). Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level. Transfusion. 44(4). 501–508.
5.
Arpino, Grazia, V J Bardou, Gary M. Clark, & Richard Elledge. (2004). Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Research. 6(3). R149–56.
6.
Arpino, Grazia, et al.. (2003). Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer. Annals of Oncology. 14(2). 233–241.
7.
Osborne, C. Kent, V J Bardou, Torsten Hopp, et al.. (2003). Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer. JNCI Journal of the National Cancer Institute. 95(5). 353–361.
8.
Viret, F., Christian Chabannon, Danielle Sainty, et al.. (2003). Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy. Bone Marrow Transplantation. 32(11). 1059–1064.
9.
Moutardier, Vincent, Marc Giovannini, Bernard Lelong, et al.. (2002). A phase II single institutional experience with preoperative radiochemotherapy in pancreatic adenocarcinoma. European Journal of Surgical Oncology. 28(5). 531–539.
10.
Bouabdallah, Réda, A.-M. Stoppa, Diane Coso, et al.. (2001). Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin’s lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutive ISC trials. Annals of Oncology. 12(4). 513–517.
11.
Giovannini, Marc, V J Bardou, Robert L. Barclay, et al.. (2001). Anal Carcinoma: Prognostic Value of Endorectal Ultrasound (ERUS). Results of a Prospective Multicenter Study. Endoscopy. 33(3). 231–236.
12.
Viens, Patrice, J Jacquemier, V J Bardou, et al.. (1999). Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy. Breast Cancer Research and Treatment. 54(3). 205–212.
13.
Jacquemier, Jocelyne, Frédérique Penault‐Llorca, François Bertucci, et al.. (1998). Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. The Journal of Pathology. 184(2). 130–135.
14.
Seitz, Jean‐François, et al.. (1998). 5-Fluorouracil, High-Dose Folinic Acid and Mitomycin C Combination Chemotherapy in Previously Treated Patients with Advanced Colorectal Carcinoma. Journal of Chemotherapy. 10(3). 258–265.
15.
Xerri, Luc, V J Bardou, A.-M. Stoppa, et al.. (1998). Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center. Annals of Oncology. 9(6). 619–625.
16.
Vey, Norbert, Patrice Viens, V J Bardou, et al.. (1998). Second Neoplasms Following High-dose Chemotherapy and Autologous Stem Cell Transplantation for Malignant Lymphomas: A Report of Six Cases in a Cohort of 171 Patients from a Single Institution. Leukemia & lymphoma. 31(1-2). 187–194.
17.
Jacquemier, Jocelyne, Frédérique Penault‐Llorca, François Bertucci, et al.. (1998). Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. The Journal of Pathology. 184(2). 130–135.
18.
Socié, Gèrard, J Cahn, Vernant Jp, et al.. (1997). Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). British Journal of Haematology. 97(4). 865–870.
19.
Stoppa, A.-M., Réda Bouabdallah, Christian Chabannon, et al.. (1997). Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 15(5). 1722–1729.
20.
Seitz, Jean‐François, Christophe Renou, Hervé Perrier, et al.. (1997). [Recurrence after surgical treatment of epidermoid cancers of the esophagus. Therapeutic approach in 19 patients].. PubMed. 21(4). 287–92.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by H D Sinnett Breakdown of academic impact, for papers by Wendy Recant Breakdown of academic impact, for papers by H. Hausmaninger Breakdown of academic impact, for papers by K. Hacène Breakdown of academic impact, for papers by Fujio Kasumi Breakdown of academic impact, for papers by Masataka Yoshimoto Breakdown of academic impact, for papers by Sami Diab Breakdown of academic impact, for papers by M. Tubiana-Hulin Breakdown of academic impact, for papers by Volker Möbus Breakdown of academic impact, for papers by Stig B. Holmberg